Copy to clipboard 
THINK Surgical entered into a development and distribution agreement with Curexo. The two have a strong working relationship based on historical development collaboration, and Curexo distributes THINK’s TSolution One™ platform in Korea and Vietnam.
THINK and Curexo will work together to include certain existing THINK technology and certain newly-developed technology in Curexo’s CUVIS-Joint orthopedic surgical robot platform. THINK will have exclusive rights to distribute the CUVIS-Joint robotic platform, including the additional technology, in the U.S. and other countries including the U.K. and certain countries in the EU.
The CUVIS-Joint robotic platform is currently being used by surgeons in Korea and India. To date, over 4,000 procedures have been performed. Curexo will continue to commercialize the CUVIS-Joint robotic platform, including new technology developed with THINK, outside of the countries in THINK’s distribution territory. Curexo will also continue to distribute THINK’s TSolution One platform.
THINK will be responsible for seeking FDA 510(k) clearance, with sales support from Curexo. The companies will work together to seek regulatory clearance in other countries for the CUVIS-Joint robotic platform, including additional technology.
“We are excited to deepen our relationship with Curexo and look forward to bringing the CUVIS-Joint platform to the United States and other markets,” said Stuart Simpson, President and CEO of THINK Surgical. “CUVIS-Joint is the next generation of active robot for joint replacement featuring an open implant library. As an open system that works with implants from multiple manufacturers, CUVIS-Joint is an outstanding fit within THINK’s portfolio of products and services. THINK’s open systems, including the CUVIS-Joint, offer a compelling alternative to closed systems which are limited to one manufacture’s implants.”
Source: THINK Surgical, Inc.
